Identification of the pyridoxal 5′‐phosphate allosteric site in human pyridox(am)ine 5′‐phosphate oxidase
Protein Science · 2024-02 · 33 (2)
DOI: 10.1002/pro.4900 ↗At a glance
Journal article in Protein Science, published online on 2024-01-23. Written by Anna Barile and 11 co-authors. Institution: Istituto di Biologia e Patologia Molecolari, Consiglio Nazionale delle Ricerche, Rome, Italy. Major MEDLINE topics: Oxidoreductases, Pyridoxaminephosphate Oxidase. Cited 8 times so far (Crossref); 28 references. The full text is freely available (open access, CC BY 4.0). Funded by: Consiglio Nazionale delle Ricerche (CNR), Sapienza Università di Roma, Istituto Pasteur Italia-Fondazione Cenci Bolognetti.
Abstract (original language)
Adequate levels of pyridoxal 5′‐phosphate (PLP), the catalytically active form of vitamin B 6 , and its proper distribution in the body are essential for human health. The PLP recycling pathway plays a crucial role in these processes and its defects cause severe neurological diseases. The enzyme pyridox(am)ine 5′‐phosphate oxidase (PNPO), whose catalytic action yields PLP, is one of the key players in this pathway. Mutations in the gene encoding PNPO are responsible for a severe form of neonatal epilepsy. Recently, PNPO has also been described as a potential target for chemotherapeutic agents. Our laboratory has highlighted the crucial role of PNPO in the regulation of PLP levels in the cell, which occurs via a feedback inhibition mechanism of the enzyme, exerted by binding of PLP at an allosteric site. Through docking analyses and site‐directed mutagenesis experiments, here we identified the allosteric PLP binding site of human PNPO. This site is located in the same protein region as the allosteric site we previously identified in the Escherichia coli enzyme homologue. However, the identity and arrangement of the amino acid residues involved in PLP binding are completely different and resemble those of the active site of PLP‐dependent enzymes. The identification of the PLP allosteric site of human PNPO paves the way for the rational design of enzyme inhibitors as potential anti‐cancer compounds.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Istituto di Biologia e Patologia Molecolari, Consiglio Nazionale delle Ricerche, Rome, Italy.
- Sapienza Università di Roma, Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Rome, Italy.
- Dipartimento di Scienze Biochimiche "A. Rossi Fanelli", Sapienza Università di Roma, Rome, Italy.
ORCID profiles: Roberto Contestabile, Angela Tramonti
Funding
- Consiglio Nazionale delle Ricerche (CNR)
- Sapienza Università di Roma
- Istituto Pasteur Italia-Fondazione Cenci Bolognetti
- European Union-NextGenerationEU
Cite
APA
Barile, A., Graziani, C., Antonelli, L., Parroni, A., Fiorillo, A., di Salvo, M. L., Ilari, A., Giorgi, A., Rosignoli, S., Paiardini, A., Contestabile, R., & Tramonti, A. (2024). Identification of the pyridoxal 5′‐phosphate allosteric site in human pyridox(am)ine 5′‐phosphate oxidase. Protein Science, 33(2). https://doi.org/10.1002/pro.4900
Vancouver
Barile A, Graziani C, Antonelli L, Parroni A, Fiorillo A, di Salvo ML, et al. Identification of the pyridoxal 5′‐phosphate allosteric site in human pyridox(am)ine 5′‐phosphate oxidase. Protein Science. 2024;33(2). doi:10.1002/pro.4900
BibTeX
@article{Barile2024,
author = {Barile, Anna and Graziani, Claudio and Antonelli, Lorenzo and Parroni, Alessia and Fiorillo, Annarita and di Salvo, Martino Luigi and Ilari, Andrea and Giorgi, Alessandra and Rosignoli, Serena and Paiardini, Alessandro and Contestabile, Roberto and Tramonti, Angela},
title = {Identification of the pyridoxal 5′‐phosphate allosteric site in human pyridox(am)ine 5′‐phosphate oxidase},
journal = {Protein Science},
year = {2024},
volume = {33},
number = {2},
doi = {10.1002/pro.4900}
}
EUVIMED